Illumina, Inc. – NASDAQ:ILMN
Illumina stock price today
$101.6
-33.67
-24.89%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in 2 days
Illumina stock price monthly change
+16.52%
month
Illumina stock price quarterly change
+16.52%
quarter
Illumina stock price yearly change
-5.09%
year
Illumina key metrics
Market Cap | 21.29B |
Enterprise value | N/A |
P/E | -8.16 |
EV/Sales | N/A |
EV/EBITDA | N/A |
Price/Sales | 7.85 |
Price/Book | 5.45 |
PEG ratio | 0.01 |
EPS | -8.15 |
Revenue | 4.49B |
EBITDA | 921M |
Income | -1.29B |
Revenue Q/Q | -1.01% |
Revenue Y/Y | 1.03% |
Profit margin | -96.12% |
Oper. margin | -91.18% |
Gross margin | 64.83% |
EBIT margin | -91.18% |
EBITDA margin | 20.5% |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeIllumina stock price history
Illumina stock forecast
Illumina financial statements
Average Price Target
$140
Potential upside: 37.79%
Analysts Price target
Financials & Ratios estimates
| Jul 2023 | 1.17B | -234M | -19.9% |
|---|---|---|---|
| Oct 2023 | 1.11B | -754M | -67.38% |
| Dec 2023 | 1.12B | -176M | -15.69% |
| Mar 2024 | 1.07B | -126M | -11.71% |
| Jul 2023 | 11774000000 | 5.21B | 44.33% |
|---|---|---|---|
| Oct 2023 | 10122000000 | 4.22B | 41.73% |
| Dec 2023 | 10111000000 | 4.36B | 43.18% |
| Mar 2024 | 10040000000 | 4.30B | 42.89% |
| Jul 2023 | 105M | -37M | -3M |
|---|---|---|---|
| Oct 2023 | 139M | -54M | -707M |
| Dec 2023 | 223M | -85M | -26M |
| Mar 2024 | 77M | -48M | 35M |
Illumina alternative data
Illumina Social Media Accounts
What are followers?
+0.11%
month
| May 2025 | 12995 |
|---|---|
| Jul 2025 | 13154 |
| Aug 2025 | 13169 |
Illumina
| 13 Aug 2023 | 72 |
|---|---|
| 20 Aug 2023 | 70 |
| 27 Aug 2023 | 72 |
| 3 Sep 2023 | 68 |
| 10 Sep 2023 | 83 |
| 17 Sep 2023 | 94 |
| 24 Sep 2023 | 69 |
| 1 Oct 2023 | 73 |
| 8 Oct 2023 | 75 |
| 15 Oct 2023 | 70 |
| 22 Oct 2023 | 76 |
| 29 Oct 2023 | 61 |
| 5 Nov 2023 | 67 |
| 12 Nov 2023 | 77 |
| 19 Nov 2023 | 66 |
| 26 Nov 2023 | 76 |
| 3 Dec 2023 | 74 |
| 10 Dec 2023 | 74 |
| 17 Dec 2023 | 73 |
| 24 Dec 2023 | 65 |
Numbers represent search interest relative to the highest point on the chart for the given region and time.
A value of 100 is the peak popularity for the term.
A value of 50 means that the term is half as popular.
A score of 0 means there was not enough data for this term.
What is job openings count?
| Sep 2023 | 137 |
|---|---|
| Oct 2023 | 185 |
| Nov 2023 | 148 |
| Dec 2023 | 140 |
| Jan 2024 | 157 |
| Feb 2024 | 175 |
| Apr 2024 | 185 |
| May 2024 | 200 |
| Jun 2024 | 173 |
| Jul 2024 | 143 |
| Dec 2024 | 204 |
| Jan 2025 | 195 |
| Feb 2025 | 234 |
| May 2025 | 237 |
| Jul 2025 | 250 |
| Aug 2025 | 207 |
| Sep 2023 | 11,500 |
|---|---|
| Oct 2023 | 11,500 |
| Nov 2023 | 11,500 |
| Dec 2023 | 11,500 |
| Jan 2024 | 11,500 |
| Feb 2024 | 11,500 |
| Mar 2024 | 10,590 |
| Apr 2024 | 10,590 |
| May 2024 | 10,590 |
| Jun 2024 | 10,590 |
| Jul 2024 | 10,590 |
Illumina other data
89.59%
+0.61%
of ILMN is owned by hedge funds
993
-36
135.27M
-855.40K
shares is hold by hedge funds
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| May 2023 | 0 | 5000 |
| Jun 2023 | 0 | 500 |
| Jul 2023 | 0 | 500 |
| Aug 2023 | 0 | 500 |
| Nov 2023 | 0 | 315 |
| Feb 2024 | 7330 | 0 |
| Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
|---|---|---|---|---|---|---|---|
Purchase | THAYSEN JACOB director, officer.. | Common Stock | 692 | $137.18 | $94,929 | ||
Purchase | THAYSEN JACOB director, officer.. | Common Stock | 692 | $137.18 | $94,929 | ||
Purchase | THAYSEN JACOB director, officer.. | Common Stock | 1,553 | $135.69 | $210,727 | ||
Purchase | THAYSEN JACOB director, officer.. | Common Stock | 1,553 | $135.69 | $210,727 | ||
Purchase | THAYSEN JACOB director, officer.. | Common Stock | 5,085 | $134.91 | $686,017 | ||
Purchase | THAYSEN JACOB director, officer.. | Common Stock | 5,085 | $134.91 | $686,017 | ||
Sale | HOYT AIMEE L officer: SVP, Chi.. | Common Stock | 315 | $112.84 | $35,545 | ||
Sale | TOUSI SUSAN H officer: SVP, Chi.. | Common Stock | 500 | $167.04 | $83,520 | ||
Sale | TOUSI SUSAN H officer: SVP, Chi.. | Common Stock | 500 | $190.08 | $95,040 | ||
Sale | TOUSI SUSAN H officer: SVP, Chi.. | Common Stock | 500 | $200 | $100,000 |
| Patent |
|---|
Grant Filling date: 4 Nov 2020 Issue date: 13 Sep 2022 |
Application Filling date: 23 May 2022 Issue date: 8 Sep 2022 |
Application Filling date: 2 Mar 2022 Issue date: 8 Sep 2022 |
Grant Filling date: 21 Mar 2020 Issue date: 6 Sep 2022 |
Application Filling date: 16 May 2022 Issue date: 1 Sep 2022 |
Application Filling date: 5 May 2022 Issue date: 1 Sep 2022 |
Grant Design: Flow cell device Filling date: 25 Nov 2019 Issue date: 30 Aug 2022 |
Grant Filling date: 26 Sep 2019 Issue date: 30 Aug 2022 |
Grant Filling date: 31 Jan 2018 Issue date: 30 Aug 2022 |
Grant Utility: Systems and devices for characterization and performance analysis of pixel-based sequencing Filling date: 14 May 2020 Issue date: 23 Aug 2022 |
| Quarter | Transcript |
|---|---|
| Q1 2024 2 May 2024 | Q1 2024 Earnings Call Transcript |
| Q4 2023 8 Feb 2024 | Q4 2023 Earnings Call Transcript |
| Q3 2023 9 Nov 2023 | Q3 2023 Earnings Call Transcript |
| Q2 2023 10 Aug 2023 | Q2 2023 Earnings Call Transcript |
Illumina: The Stock Is Still Undervalued
Icahn Enterprises: Paying 66% Premium To Tangible NAV? For What, Exactly?
Illumina: Higher Profit Margin Despite GRAIL Divestiture And Macroeconomic Headwinds
Pacific Biosciences: A Mountain Of Red Flags
GRAIL's Galleri Progresses While Back In Accumulation Levels
Undercovered Dozen: Telus Corporation, X-FAB Silicon Foundries, GRAIL, And More
Illumina: Marriage Made In Hell Is (Finally) Over - Assessing Impact Of GRAIL Spin-Out
GRAIL: Ambitious Illumina Spin-Off Trading At Intriguing Valuation
Illumina: One Of The Most Hated Stocks In Healthcare Is Looking Like A Strong Buy
-
What's the price of Illumina stock today?
One share of Illumina stock can currently be purchased for approximately $101.6.
-
When is Illumina's next earnings date?
Unfortunately, Illumina's (ILMN) next earnings date is currently unknown.
-
Does Illumina pay dividends?
No, Illumina does not pay dividends.
-
How much money does Illumina make?
Illumina has a market capitalization of 21.29B and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 0.49% to 4.5B US dollars.
-
What is Illumina's stock symbol?
Illumina, Inc. is traded on the NASDAQ under the ticker symbol "ILMN".
-
What is Illumina's primary industry?
Company operates in the Healthcare sector and Medical - Diagnostics & Research industry.
-
How do i buy shares of Illumina?
Shares of Illumina can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Illumina's key executives?
Illumina's management team includes the following people:
- Mr. Sam A. Samad Chief Financial Officer(age: 55, pay: $716,040)
- Ms. Susan H. Tousi Chief Commercial Officer(age: 56, pay: $655,310)
- Dr. Alexander Aravanis M.D., Ph.D. Chief Technology Officer & Head of Research and Product Devel.(age: 49, pay: $416,480)
-
How many employees does Illumina have?
As Jul 2024, Illumina employs 10,590 workers.
-
When Illumina went public?
Illumina, Inc. is publicly traded company for more then 25 years since IPO on 28 Jul 2000.
-
What is Illumina's official website?
The official website for Illumina is illumina.com.
-
Where are Illumina's headquarters?
Illumina is headquartered at 5200 Illumina Way, San Diego, CA.
-
How can i contact Illumina?
Illumina's mailing address is 5200 Illumina Way, San Diego, CA and company can be reached via phone at 858 202 4500.
-
What is Illumina stock forecast & price target?
Based on 8 Wall Street analysts` predicted price targets for Illumina in the last 12 months, the avarage price target is $140. The average price target represents a 37.79% change from the last price of $101.6.
Illumina company profile:
Illumina, Inc.
illumina.comExchange:
NASDAQ
Full time employees:
10,590
Industry:
Medical - Diagnostics & Research
Sector:
Healthcare
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. The company provides instruments and consumables used in genetic analysis; and genotyping and sequencing services, instrument service contracts, and development and licensing agreements, as well as cancer detection testing services. Its customers include genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers in North America, Europe, Latin America, and the Asia-Pacific region, as well as sells through life-science distributors in various markets within Europe, the Asia-Pacific region, Latin America, the Middle East, and Africa. The company was incorporated in 1998 and is based in San Diego, California.
5200 Illumina Way
San Diego, CA 92122
San Diego, CA 92122
CIK: 0001110803
ISIN: US4523271090
CUSIP: 452327109
